The National Gonorrhea Therapy Monitoring Study: I. Review of treatment results and of in-vitro antibiotic susceptibility, 1972-1978.
D000658:Amoxicillin / Q000627:therapeutic use; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004338:Drug Combinations; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects* / Q000302:isolation & purification; D010402:Penicillin G Procaine / Q000008:administration & dosage / Q000627:therapeutic use; D010403:Penicillin Resistance; D011339:Probenecid / Q000627:therapeutic use; D011446:Prospective Studies; D000198:Spectinomycin / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014481:United States
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D010402:Penicillin G Procaine; D000667:Ampicillin; D000658:Amoxicillin; D000198:Spectinomycin; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D011339:Probenecid